Seven Bridges Stock
Seven Bridges is the leading biomedical data science company.
About Seven Bridges Stock
Seven Bridges is the industry-leading infrastructure and data analytics company accelerating precision medicine by enabling the understanding of biomedical data. Our platform, services, and support expertise are driving discovery and drug development at the world’s leading academic, biotechnology, government, hospitals, and pharmaceutical entities. Through our collaborations with the largest genomics projects, we connect the world’s biomedical information to enable the most efficient analysis at scale. Named one of the world's smartest companies by MIT Technology Review, and a three-time Bio-IT World Best of Show winner, Seven Bridges has offices in Belgrade, Boston, Istanbul, and San Francisco.
Funding History
| September 2014 | $3.0M |
|---|---|
| February 2016 | $45.0M |
| April 2018 | $50.0M |
Management
Co-Founder
Igor Bogicevic
Director of Program Management
Jack DiGiovanna
Senior Data Scientist
Nan Xiao
Chief Product Officer
Milan Mitrovic
Chief Scientific Officer
Brandi Davis-Dusenbery
Co-Founder
Deniz Kural
Chief Technology Officer
Mladen Srdic
Chief Financial Officer
Robert Shay
Chief Executive Officer
William Moss
Chief Revenue Officer
Bruce Press
Press
In Honor of Seven Bridges
New York Times - Mar, 21 2019
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Seven Bridges or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
